Advanced Wound Care Market by Product (Wound Dressings (Foams, Hydrocolloids, Alginates, Collagen), Therapy Devices (Electrical Devices, Pressure Relief Devices) Active Wound Care (Autograft, Allograft), Wound Type (Surgical, Trauma, Ulcers, Burns), End User (Hospital, Home Care) – Analysis & Forecast 2019-2030

Advanced Wound Care Market Overview and Introduction

The global advanced wound care market is estimated to be over US$ 8.5 Bn in 2017. It is anticipated to grow at a CAGR of 4.3% from 2019 to 2030.

Advanced wound care products are widely used to treat more complex wounds that require wound hydration and promote healing. The products are used as moisture therapy and applied around the wound area. Also these products provide protection from bacterial infection and other foreign elements thus maintaining stable temperature around the wound, protection from infection, removal of dead tissues, assistance in oxygenation, and relieve in pain.

The global market is driven by technological advancements in the wound therapy arena, increasing patient awareness and health care expenditure, rising prevalence of chronic wounds, and rising need for treatment of complex wounds are major factors driving the market. However, high cost related to advance wound care products is likely to restrain the market to certain extent.

Advanced Wound Care Market by Product 

On the basis of product, the advanced wound care market is segmented into wound dressings, wound therapy devices, and active wound care. The wound dressing segment is further sub-segmented into hydrocolloid, alginate, foam, and collagen dressings. The wound therapy devices segment is further categorized into pressure relief devices; negative pressure wound therapy systems, electrical devices and other wound therapy devices. The active wound care market is further segmented into autografts, allografts and others. The wound dressings segment is estimated to account for the largest market share of the global market. Growth of this segment can be attributed to increasing incidence of diabetes-associated ulcers and others and focus of companies to innovative advanced wound dressings for the treatment wounds.

Advanced Wound Care Market by Wound Type 

Based on wound type, the market is segmented into surgical wounds, ulcers, traumatic wounds, burns, and other wounds. The surgical wounds segment is estimated to account for the largest share of the global market. The large share of this segment can be attributed to the rising incidence of diabetic foot ulcers & pressure ulcers and increasing prevalence of post-operative surgical wounds.

Advanced Wound Care Market by End User 

On the basis of end user, This market is segmented into hospitals and clinics, home care settings, and other end users. The hospitals and clinics segment is estimated to account for the largest share of the advanced wound care market. Increasing wounds related to diabetic foot, and venous leg ulcer and the rising incidence of hospital-acquired pressure ulcers are some of the factors driving the growth of end-user segment.

Advanced Wound Care Market by Regions 

The global market can be segmented into North America, Europe, Asia Pacific, and Rest of World (ROW).  North America dominated the market of advance wound care, followed by Europe and Asia Pacific. North America will continue to dominate the global market in the forecast period owing to factors such as growing need of advance wound care products and highly developed healthcare system. However, Asia Pacific is expected to witness the highest CAGR, with the growth in this market centered at China, India, and Japan. Factors such as the rising focus of major players in emerging Asian countries and government support are driving the growth of the market in this region. The high cost of advanced wound care products and chronic wound treatment may restrain market growth to a certain extent.

Advanced Wound Care Market Prominent Players 

The prominent players in the global advanced wound care market are Smith & Nephew, B. Braun, ConvaTec Group, Integra LifeSciences, 3M, Cardinal Health, Medtronic, MPM Medical, Paul HARTMANN, and MiMedx Group, among others.